Literature DB >> 10430710

Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts.

A J Newman Taylor1, P Cullinan, P A Lympany, J M Harris, R J Dowdeswell, R M du Bois.   

Abstract

The development of sensitization to inhaled allergens is determined by the interaction of multiple genetic and environmental influences. Occupational sensitization to low-molecular-weight chemicals allows a specific immunological response to an inhaled hapten to be studied in a well-defined population with characterized exposure. We investigated the workforce of a large platinum refinery exposed to ammonium hexachloroplatinate (ACP) to test the hypothesis that the development of IgE-associated sensitization to ACP was influenced by human leukocyte-associated antigen (HLA) phenotype, especially in those with lower ACP exposure. We performed HLA typing in 44 cases with a positive skin prick test to ACP, and 57 nonsensitized referents matched on age, race, duration of employment, and category of ACP exposure. An HLA-DR3 phenotype was more common among cases (odds ratio [OR] 2.3), and more so in those with low (OR infinite) than with high exposure (OR 1.6); HLA-DR6 was less common among the cases (OR 0.4), an association also stronger in the low-exposure group (OR 0.1 versus 0.5). These results provide evidence that HLA phenotype is a significant determinant of sensitization to complex platinum salts and for the first time show that the strength of this association varies with intensity of exposure to the sensitizing agent. They imply that as exposure-control measures are taken to prevent occupational sensitization and, by analogy, sensitization to allergens outside the workplace, disease incidence will increasingly be determined by genetic susceptibility.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430710     DOI: 10.1164/ajrccm.160.2.9807065

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  14 in total

Review 1.  Gene-environment interactions in asthma.

Authors:  F Castro-Giner; F Kauffmann; R de Cid; M Kogevinas
Journal:  Occup Environ Med       Date:  2006-11       Impact factor: 4.402

2.  Oxaliplatin rechallenge in metastatic colorectal cancer patients after prior oxaliplatin treatment.

Authors:  Jae-Joon Kim; Jihoon Kang; Yong Sang Hong; Kyu-Pyo Kim; Sun Young Kim; Tae Won Kim; Jeong Eun Kim
Journal:  Med Oncol       Date:  2018-04-05       Impact factor: 3.064

3.  Incidence by occupation and industry of acute work related respiratory diseases in the UK, 1992-2001.

Authors:  J C McDonald; Y Chen; C Zekveld; N M Cherry
Journal:  Occup Environ Med       Date:  2005-12       Impact factor: 4.402

Review 4.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

Review 5.  Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication.

Authors:  Ming-Yang Lee; Muh-Hwa Yang; Jin-Hwang Liu; Chueh-Chuan Yen; Pang-Chan Lin; Hao-Wei Teng; Wei-Shu Wang; Tzeon-Jye Chiou; Po-Min Chen
Journal:  Support Care Cancer       Date:  2006-07-25       Impact factor: 3.603

6.  Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.

Authors:  M Wasif Saif; Shailja Roy; Leslie Ledbetter; Jennifer Madison; Kostas Syrigos
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

7.  Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.

Authors:  Nektaria Makrilia; Ekaterini Syrigou; Ioannis Kaklamanos; Leonidas Manolopoulos; Muhammad Wasif Saif
Journal:  Met Based Drugs       Date:  2010-09-20

8.  Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan.

Authors:  Yoshihiro Shibata; Hiroshi Ariyama; Eishi Baba; Yasushi Takii; Taito Esaki; Kenji Mitsugi; Tanji Tsuchiya; Hitoshi Kusaba; Koichi Akashi; Shuji Nakano
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

Review 9.  Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.

Authors:  Ekaterini Syrigou; Kostas Syrigos; M Wasif Saif
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

10.  Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma.

Authors:  Berran Yucesoy; Victor J Johnson; Zana L Lummus; Michael L Kashon; Marepalli Rao; Hansen Bannerman-Thompson; Bonnie Frye; Wei Wang; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Dori R Germolec; Michael I Luster; David I Bernstein
Journal:  J Occup Environ Med       Date:  2014-04       Impact factor: 2.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.